Category : Search result: medicines investment


Little-Pengelly presses Starmer on Brexit grace periods

Northern Ireland's deputy First Minister has called on the Prime Minister to extend grace periods for post-Brexit rules on vet medicines and cars, warning of market disruption. Read the latest from the British-Irish Council.

William Champions Wales at Major Investment Summit

The Prince of Wales will address over 250 firms at a landmark summit in Newport, promoting Wales as a hub for tech, innovation, and skilled talent. Discover the key sectors and opportunities.

NHS patients may get only generic drugs, warns AstraZeneca

The CEO of pharmaceutical giant AstraZeneca warns that NHS patients may be limited to generic medicines unless the health service increases what it pays for branded drugs, raising concerns about access to cutting-edge treatments.

UK probes Pfizer and Novo Nordisk investments

The UK government launches a national security probe into major pharmaceutical investments by US-based Pfizer and Denmark's Novo Nordisk, raising concerns about foreign influence in Britain's vital healthcare sector.

Rachel Reeves courts Gulf states for UK investment

Chancellor Rachel Reeves is actively seeking investment from Gulf nations including Saudi Arabia, raising questions about economic pragmatism versus ethical foreign policy in Labour's new government.

Dangerous Weight Loss Drugs Flood UK Market

Exclusive investigation reveals dangerous counterfeit weight loss medications are being illegally sold across Britain, putting thousands at risk of serious health complications.

Lloyds Bank makes £450m profit from Ferrari stake sale

Exclusive analysis reveals how Lloyds Banking Group's patient investment strategy paid off spectacularly with their Ferrari stake, while Citigroup faces Hong Kong regulatory scrutiny in separate banking sector developments.

Trump Tariffs Threaten NHS Drug Price Crisis

Former President Donald Trump's proposed tariffs could dramatically increase costs for NHS medicines, potentially costing the health service billions and threatening patient care across the UK.

NHS deploys 3 new COVID drugs for vulnerable

The NHS is rolling out three groundbreaking COVID-19 treatments to protect the most vulnerable, including molnupiravir and ritonavir, offering new hope for high-risk patients across the UK.

London's AIM Market Outperforms Dow Jones

The UK's Alternative Investment Market (AIM) has delivered staggering returns that left the Dow Jones in the dust, with investment expert Russ Mould revealing which sectors drove this extraordinary performance.

UK Investor Warns of AI Stock Bubble Danger

Prominent British tech investor Eileen Burbidge warns that artificial intelligence stocks are showing worrying signs of a market bubble, drawing parallels to the dot-com era as valuations become dangerously detached from reality.

NHS Drug Pricing: The Art of the Deal Saving Millions

Exclusive insight into how NHS England's shrewd negotiation tactics secure massive discounts on vital medicines, from cancer treatments to rare disease drugs, ensuring sustainable healthcare funding.

Page 1 of 4